| scholarly article | Q13442814 |
| P50 | author | Preetha Shridas | Q88817323 |
| P2093 | author name string | Nancy R Webb | |
| Maria C De Beer | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function | Q24563622 | ||
| Molecular mechanisms regulating NLRP3 inflammasome activation | Q26778556 | ||
| Inflammasomes: mechanism of action, role in disease, and therapeutics | Q27001186 | ||
| Serum amyloid A, the major vertebrate acute-phase reactant | Q28145306 | ||
| Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R | Q28209447 | ||
| Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway | Q28236043 | ||
| Is serum amyloid A an endogenous TLR4 agonist? | Q28267453 | ||
| SAA does not induce cytokine production in physiological conditions | Q28279562 | ||
| Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A | Q28284501 | ||
| Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake | Q28294881 | ||
| Nonexpression of the Human Serum Amyloid A Three (SAA3) Gene | Q28305684 | ||
| CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells | Q28580132 | ||
| Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression | Q29615589 | ||
| The NALP3 inflammasome is involved in the innate immune response to amyloid-beta | Q29615595 | ||
| Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration | Q29615596 | ||
| NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
| Interleukin-1-receptor antagonist in type 2 diabetes mellitus | Q29619001 | ||
| NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? | Q29619524 | ||
| Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms. | Q30355344 | ||
| Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation | Q30414961 | ||
| Binding, trafficking and accumulation of serum amyloid A in peritoneal macrophages | Q30985170 | ||
| Serum amyloid A induces NLRP-3-mediated IL-1β secretion in neutrophils | Q33638132 | ||
| Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation | Q33644572 | ||
| Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients | Q33732176 | ||
| A pertussis toxin sensitive G-protein-independent pathway is involved in serum amyloid A-induced formyl peptide receptor 2-mediated CCL2 production | Q33809151 | ||
| High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. | Q34157008 | ||
| Impact of serum amyloid A on high density lipoprotein composition and levels | Q34187954 | ||
| Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria | Q50072056 | ||
| Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. | Q50917495 | ||
| NLRP3 (Nucleotide Oligomerization Domain-Like Receptor Family, Pyrin Domain Containing 3)-Caspase-1 Inflammasome Degrades Contractile Proteins: Implications for Aortic Biomechanical Dysfunction and Aneurysm and Dissection Formation. | Q51155749 | ||
| The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis. | Q54128384 | ||
| Serum amyloid A impairs the antiinflammatory properties of HDL. | Q55077919 | ||
| Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms | Q57154848 | ||
| The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein | Q58645726 | ||
| Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes | Q58645765 | ||
| Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein | Q72066987 | ||
| Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein | Q72299706 | ||
| Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse | Q73370318 | ||
| Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice | Q73865404 | ||
| The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation | Q83123575 | ||
| Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al | Q87417828 | ||
| Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2. | Q34615520 | ||
| Characterization of the oligomerization and aggregation of human Serum Amyloid A | Q34764150 | ||
| Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice | Q35058983 | ||
| Serum amyloid A and inflammation in diabetic kidney disease and podocytes | Q35138098 | ||
| NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy | Q35202688 | ||
| Regulation of inflammasome activation | Q35456425 | ||
| Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. | Q35555630 | ||
| Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL. | Q35886290 | ||
| Antiinflammatory properties of HDL. | Q35919164 | ||
| ATP release and purinergic signaling in NLRP3 inflammasome activation | Q36515084 | ||
| Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2. | Q36562118 | ||
| Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation | Q36771716 | ||
| Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases | Q36816872 | ||
| C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study | Q36953097 | ||
| High-density lipoprotein: antioxidant and anti-inflammatory properties | Q37074314 | ||
| Pathogenetic mechanisms of amyloid A amyloidosis. | Q37218553 | ||
| Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides | Q37322206 | ||
| Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization | Q37729400 | ||
| Immune functions of serum amyloid A. | Q38067156 | ||
| Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
| Cellular mechanism of fibril formation from serum amyloid A1 protein. | Q38715103 | ||
| High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. | Q38762941 | ||
| Inflammasome Priming in Sterile Inflammatory Disease. | Q39097515 | ||
| Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes | Q39943851 | ||
| Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. | Q40156771 | ||
| Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production | Q42017597 | ||
| Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status | Q42056008 | ||
| Circular-dichroism studies on two murine serum amyloid A proteins | Q42163690 | ||
| Inhibition of human caspases by peptide-based and macromolecular inhibitors | Q42538024 | ||
| A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A | Q42795983 | ||
| Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast | Q42816825 | ||
| Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. | Q43076984 | ||
| Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors | Q43746526 | ||
| Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. | Q44138778 | ||
| Macrophage inflammasome mediates hyperhomocysteinemia-aggravated abdominal aortic aneurysm. | Q46772928 | ||
| Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm | Q46816927 | ||
| Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition | Q47206788 | ||
| Serum Amyloid A3 is a High-Density Lipoprotein-associated Acute Phase Protein | Q47287451 | ||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reactive oxygen species | Q424361 |
| P304 | page(s) | 13257-13269 | |
| P577 | publication date | 2018-07-05 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation | |
| P478 | volume | 293 |
| Q91826756 | Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation |
| Q92970082 | Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis |
| Q91790389 | Effects of D-Chiro-Inositol on Glucose Metabolism in db/db Mice and the Associated Underlying Mechanisms |
| Q89783235 | High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice |
| Q64250648 | High-Density Lipoprotein from Chronic Kidney Disease Patients Modulates Polymorphonuclear Leukocytes |
| Q91972897 | Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson's Disease |
| Q90701560 | Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia |
Search more.